Loading clinical trials...
Loading clinical trials...
Cross-Sectional Study to Determine Distribution of Genetic Variants Among Subjects at Risk of, or With Known Non-alcoholic Steatohepatitis (NASH)
Conditions
Interventions
No Intervention
Locations
50
United States
Southern California Research Center
Coronado, California, United States
Velocity Clinical Research
Gardena, California, United States
UCSD Health System
La Jolla, California, United States
National Research Institute
Los Angeles, California, United States
Clinnova Research Solutions
Orange, California, United States
National Research Institute
Panorama City, California, United States
Start Date
December 9, 2021
Primary Completion Date
October 27, 2022
Completion Date
October 27, 2022
Last Updated
March 17, 2023
NCT03151473
NCT02754037
NCT06168383
NCT05989711
NCT00666016
NCT02653300
Lead Sponsor
Regeneron Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions